IPO REVIEW

Manipal Payment IPO: Analysts say 'subscribe' for listing gains; GMP at 10%

Manipal Payment IPO review: Analysts have recommended a 'Subscribe' rating on the issue for listing gains. The current GMP stands at 10 per cent.

Updated On: 09 Sep 2026 | 6:04 PM IST

Laurus Labs: Costly prescription

While the firm is getting into higher-margin formulations, the price asked for growth is on the higher side

Updated On: 06 Dec 2016 | 3:19 AM IST